- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.01. | WORK Medical Technology Group LTD - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 30.12.25 | Work Medical Technology Group schließt Aktienzusammenlegung im Verhältnis 100:1 ab | 5 | Investing.com Deutsch | ||
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| 30.12.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.12.25 | WORK Medical Shares Jump 9% On Exclusive AI Blood Analysis Deal In China | 1 | RTTNews | ||
| 29.12.25 | WORK Medical Signs East China Distribution Deal For AI Blood Analyzer, Stock Up | 1 | RTTNews | ||
| 29.12.25 | Produktionszulassung für KI-Blutanalysegerät beflügelt Aktie von WORK Medical | 2 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical subsidiary signs exclusive distribution deal for blood analyzer | 1 | Investing.com | ||
| 29.12.25 | WORK Medical schließt exklusiven Vertriebsvertrag für KI-Blutanalysegerät in Ostchina | - | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 388 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 29.12.25 | HANGZHOU - WORK Medical subsidiary receives AI blood analyzer approval | 1 | Investing.com | ||
| 29.12.25 | WORK Medical erhält Zulassung für KI-gestütztes Blutanalysegerät | 1 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer | 212 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.12.25 | WORK Medical führt Aktienzusammenlegung im Verhältnis 1:100 durch | 13 | Investing.com Deutsch | ||
| 24.12.25 | WORK Medical to implement 1-for-100 reverse stock split | 3 | Investing.com | ||
| 24.12.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 | 694 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.11.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 10 | SEC Filings | ||
| 07.11.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 04.11.25 | WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 4,707 | +0,12 % | Teladoc Health Q4 Loss Narrows | WASHINGTON (dpa-AFX) - Teladoc Health, Inc. (TDOC) on Wednesday reported a fourth-quarter net loss of $25.1 million, or $0.14 per share, compared to $48.4 million or $0.28 per share last year.Fourth-quarter... ► Artikel lesen | |
| HIMS & HERS HEALTH | 18,545 | -0,32 % | Hims & Hers Expands Integrated Digital Healthcare Ecosystem | ||
| PLUS THERAPEUTICS | 0,238 | -3,52 % | Plus Therapeutics Inc.: Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide May Reduce Leptomeningeal Metastases Healthcare Costs by 40% | ||
| CO-DIAGNOSTICS | 2,270 | 0,00 % | Co-Diagnostics expands South Asia distribution territory | ||
| VERU | 2,290 | -0,43 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| SENSEONICS | 5,700 | -0,87 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| ELEKTA | 4,950 | -6,78 % | Dividendenbekanntmachungen (05.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN ASSETS TRUST INC US0240131047 0,34 USD 0,2922 EUR ARMSTRONG WORLD INDUSTRIES INC US04247X1028 0,339 USD 0,2914 EUR ASSOCIATED... ► Artikel lesen | |
| IMUNON | 2,340 | +2,63 % | Imunon erweitert At-the-Market-Offering um 7 Millionen US-Dollar | ||
| PERSPECTIVE THERAPEUTICS | 3,640 | -1,62 % | H.C. Wainwright raises Perspective Therapeutics price target to $13 | ||
| AXE COMPUTE | 1,240 | +16,98 % | Axe Compute Inc: Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute | PITTSBURGH, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Axe Compute (or the "Company") (Nasdaq: AGPU) today announced the appointment of Christopher Miglino as Chief Executive Officer, marking a pivotal development... ► Artikel lesen | |
| AXOGEN | 26,800 | +3,88 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| MYOMO | 0,579 | -4,61 % | Myomo outlines 10% revenue growth target for 2026 while expanding recurring patient sources and international operations | ||
| MEDLINE | 36,400 | +0,55 % | Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters' option to purchase additional shares | NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) ("Medline") announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 3,355 | -2,47 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| TALKSPACE | 5,125 | -0,39 % | Universal Health Services, Inc. to Acquire Talkspace, Inc. | Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care KING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal... ► Artikel lesen |
WORK MEDICAL TECHNOLOGY GROUP LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,150 Euro und damit +3,60 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WORK MEDICAL TECHNOLOGY GROUP LTD finden Sie auf Wallstreet Online.